Skip to main content

Table 5 Correlation between shrinkage pattern and pathologic response

From: Predicting response to neo-adjuvant chemotherapy and assessment of residual disease in breast cancer using contrast-enhanced spectral mammography: a combined qualitative and quantitative approach

 

Pathologic response

P value

Responder 60/80 (75%)

Non-responder 20/80 (25%)

Count

%

Count

%

Complete response (n = 20/81, 24.75%)

20/60

33.3%

0

0%

0.002

Type I: concentric (n = 24/81, 29.6%)

17/60

28.3%

7/21

33.3%

0.666

Type II: concentric with surrounding lesions (n = 15/81, 18.5%)

7/60

11.7%

8/21

38.1%

0.018

Type III: residual multi-nodular (n = 9/81, 11.1%)

8/60

13.3%

1/21

4.8%

0.434

Type IV: diffuse enhancement (n = 9/81, 11.1%)

7/60

11.7%

2/21

9.5%

1

No response (n = 4/81, 4.95%)

1/60

1.7%

3/21

14.3%

0.052